BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1359051)

  • 1. The pharmacology of a novel topical retinoid, BMY 30123: comparison with tretinoin.
    Tramposch KM; Nair X; Gendimenico GJ; Tetrault GB; Chen S; Kiss I; Whiting G; Bonney RJ
    J Pharm Pharmacol; 1992 May; 44(5):379-86. PubMed ID: 1359051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMY 30047: a novel topically active retinoid with low local and systemic toxicity.
    Nair X; Quigley J; Tramposch KM; Carroll FI; Lewin AH; Kiss I
    J Pharmacol Exp Ther; 1991 Jan; 256(1):365-70. PubMed ID: 1988666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo activity of retinoid esters in skin is related to in-vitro hydrolysis rate.
    Chen S; Darling IM; Yu KL; Starrett JE; Mansuri MM; Whiting G; Tramposch KM
    J Pharm Pharmacol; 1995 Aug; 47(8):626-31. PubMed ID: 8583361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazacholesterol-induced ichthyosis in the hairless mouse. Assay for comparative potency of topical retinoids.
    Chung JC; Law MY; Elliott ST; Elias PM
    Arch Dermatol; 1984 Mar; 120(3):342-7. PubMed ID: 6703735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A direct comparison of pharmacologic effects of retinoids on skin cells in vitro and in vivo.
    Varani J; Gendimenico GJ; Shah B; Gibbs D; Capetola RJ; Mezick JA; Voorhees JJ
    Skin Pharmacol; 1991; 4(4):254-61. PubMed ID: 1724165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of retinoid-induced epidermal and dermal thickening from skin irritation.
    Varani J; Fligiel H; Zhang J; Aslam MN; Lu Y; Dehne LA; Keller ET
    Arch Dermatol Res; 2003 Nov; 295(6):255-62. PubMed ID: 14564458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-treatment with retinyl retinoate and a PPARĪ± agonist reduces retinoid dermatitis.
    Kim B; Kim JE; Kim H; Lee JD; Choi KY; Lee SH
    Int J Dermatol; 2012 Jun; 51(6):733-41. PubMed ID: 22607296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical and systemic effects of retinoids on horn-filled utriculus size in the rhino mouse. A model to quantify "antikeratinizing" effects of retinoids.
    Mezick JA; Bhatia MC; Capetola RJ
    J Invest Dermatol; 1984 Aug; 83(2):110-3. PubMed ID: 6206163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
    Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
    Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models.
    Chen S; Ostrowski J; Whiting G; Roalsvig T; Hammer L; Currier SJ; Honeyman J; Kwasniewski B; Yu KL; Sterzycki R
    J Invest Dermatol; 1995 May; 104(5):779-83. PubMed ID: 7738355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids.
    Connor MJ; Lowe NJ
    Cancer Res; 1983 Nov; 43(11):5174-7. PubMed ID: 6616453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
    Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
    Sakuta T; Kanayama T
    Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of retinoids as therapeutic agents in dermatology.
    Lewin AH; Bos ME; Zusi FC; Nair X; Whiting G; Bouquin P; Tetrault G; Carroll FI
    Pharm Res; 1994 Feb; 11(2):192-200. PubMed ID: 8165176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones.
    Bernerd F; Ortonne JP; Bouclier M; Chatelus A; Hensby C
    Arch Dermatol Res; 1991; 283(2):100-7. PubMed ID: 2069410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial tolerability of topical retinoid therapy.
    Leyden J; Grove G; Zerweck C
    J Drugs Dermatol; 2004; 3(6):641-51. PubMed ID: 15624747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of retinoids on phorbol ester-stimulated epidermal DNA synthesis and hyperplasia in hairless mice.
    Gendimenico GJ; Nair X; Bouquin PL; Tramposch KM
    J Invest Dermatol; 1989 Sep; 93(3):363-7. PubMed ID: 2768837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of epidermal transglutaminase activity and terminal differentiation by retinoids and phorbol esters.
    Yuspa SH; Ben T; Lichti U
    Cancer Res; 1983 Dec; 43(12 Pt 1):5707-12. PubMed ID: 6139162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topical retinoids on cytoskeletal proteins: implications for retinoid effects on epidermal differentiation.
    Eichner R; Kahn M; Capetola RJ; Gendimenico GJ; Mezick JA
    J Invest Dermatol; 1992 Feb; 98(2):154-61. PubMed ID: 1370674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous retinoid absorption and embryotoxicity.
    Willhite CC; Sharma RP; Allen PV; Berry DL
    J Invest Dermatol; 1990 Nov; 95(5):523-9. PubMed ID: 2230214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.